Postnatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Young Adult Metabolic Phenotype

BACKGROUND: Rosiglitazone (RGZ), a peroxisome proliferator-activated receptor-γ (PPARγ) agonist, significantly enhances lung maturation without affecting blood biochemical and metabolic profiles in the newborn period. However, whether this exposure to RGZ in neonatal life alters the adult metabolic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Truong, Nghia C., Abbasi, Afshan, Sakurai, Reiko, Lee, W.N. Paul, Torday, John S., Rehan, Virender K.
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2012
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388271/
https://ncbi.nlm.nih.gov/pubmed/22076469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000331772
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki